News from oncobiologics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 14, 2015, 08:41 ET

Oncobiologics Expands its Board of Directors with the Appointment of Three New Independent Members

 Oncobiologics, Inc. (Oncobiologics) announces the expansion of its Board of Directors with the appointment of Albert D. Dyrness, Kurt J....

Oct 05, 2015, 08:00 ET

Oncobiologics Announces ONS-1045 (Avastin®/bevacizumab biosimilar) Meets Primary and Secondary Endpoints in Phase 1 Clinical Trial

 Oncobiologics, Inc. ("Oncobiologics") announced that its bevacizumab (Avastin®) biosimilar candidate, ONS-1045, met the primary and...

Sep 29, 2015, 08:00 ET

Oncobiologics Secures Financing from Sabby Management, LLC, to Advance BioSymphony™ Platform and Monoclonal Antibody Biosimilars Pipeline

Oncobiologics, Inc. ("Oncobiologics") announced that it closed an additional round of financing with Sabby Management, LLC. This equity financing,...

Sep 16, 2015, 08:00 ET

Oncobiologics Appoints Lawrence A. Kenyon as Chief Financial Officer

Oncobiologics, Inc. announced the appointment of Lawrence A. Kenyon as its Chief Financial Officer (CFO), effective September 15, 2015. Mr....

Jul 27, 2015, 07:45 ET

Oncobiologics Secures $31 Million Financing to Advance BioSymphony™ Platform Development and Monoclonal Antibody Biosimilars Pipeline

 Oncobiologics, Inc., announced the closing of a $31 million financing.  Proceeds will be used to support continued development and...

May 04, 2015, 10:15 ET

Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey

 Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing monoclonal antibody (mAb) biosimilars, has completed...

Apr 15, 2015, 10:00 ET
Oncobiologics Logo

Oncobiologics announces completion of clinical dosing for bevacizumab (Avastin® biosimilar) candidate

 Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing biosimilars, today announced that clinical...

Feb 12, 2015, 09:00 ET
Oncobiologics Logo

Oncobiologics announces ONS-3010 (Humira®/adalimumab biosimilar) meets primary endpoints in first clinical study

 Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing biosimilars, announced today that ONS-3010, its...

Oct 07, 2014, 09:30 ET
Oncobiologics Logo (PRNewsFoto/Oncobiologics, Inc.)

Oncobiologics Appoints Dr. Todd C. Brady to its Board of Directors

 Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing complex biosimilars, announced the appointment of...

Jul 16, 2014, 09:00 ET

Strides Arcolab makes strategic investment in Oncobiologics, Inc., USA

Strides Arcolab and Oncobiologics, Inc., today announced that Strides has made a series of strategic investments in Oncobiologics, Inc., a...

Jun 26, 2014, 09:30 ET

Liomont and Oncobiologics partner to launch Biosimilars in Mexico

CRANBURY, N.J., June 26, 2014 /PRNewswire/ -- Oncobiologics, Inc. and Laboratorios Liomont S.A. de C.V. announced today a strategic...

Jun 12, 2014, 09:30 ET

Oncobiologics launches Phase I Clinical Trial for ONS-3010 Biosimilar version of Humira®

 Oncobiologics, Inc. announced today that it has received approval to initiate a Phase I clinical trial in Europe for its first biosimilar...

Jun 02, 2014, 09:00 ET

Ipca and Oncobiologics Create Strategic Biosimilars Partnership

Ipca Laboratories Ltd., India (Ipca) and Oncobiologics, Inc., USA (Oncobiologics) announced today the creation of a two-part...

Aug 06, 2013, 10:00 ET

Oncobiologics and inVentiv Health Form Strategic Partnership around Biosimilars

 Oncobiologics, Inc. and inVentiv Health today announced a broad strategic partnership around clinical development for all assets in...

May 08, 2013, 09:00 ET

Huahai and Oncobiologics Create Broad Biosimilars Partnership

 Oncobiologics, Inc. announced today that Zhejiang Huahai Pharmaceutical Co., Ltd and Oncobiologics have signed an alliance agreement for the...

Feb 25, 2013, 09:41 ET

Viropro and Oncobiologics Sign Emerging Markets Biosimilars Deal

 Viropro, Inc. (OTC: VPRO) and Oncobiologics, Inc. announced today the signing of a biosimilar collaboration agreement.  Under the...

Nov 06, 2012, 08:35 ET

Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets

 Oncobiologics, Inc. and Boston Oncology, LLC today announced a strategic partnership that will allow Boston Oncology to license, manufacture,...

Jul 30, 2012, 10:00 ET

Oncobiologics, Inc. Announces a Collaboration Agreement with XOMA Corporation to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform

Oncobiologics, Inc. announced today a collaboration agreement with XOMA Corporation to develop novel biotherapeutics based on engineering...

May 25, 2012, 07:50 ET

Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board

 Oncobiologics, Inc. announced today that it has filled two important leadership positions with established biopharmaceutical industry experts....

Oct 17, 2011, 10:00 ET
Pictured at the grand opening ribbon cutting event are (from left): Alfred Titone, U.S. Small Business Administration, New Jersey District Director; Pankaj Mohan, Ph.D., Oncobiologics, Founder & CEO; Lt. Gov. Kim Guadagno; Debbie Hart, BioNJ President; Sen. Robert Menendez; and Jeremy Caudill, Oncobiologics, Vice President Business Development.  (PRNewsFoto/Oncobiologics, Inc., Lauren Rutten)

Senator Menendez, Lt. Governor Guadagno Unveil New Biotech Firm Oncobiologics

Sen. Robert Menendez (D-NJ), Lt. Gov. Kim Guadagno and regional leaders of the biopharmaceutical industry Friday unveiled the state-of-the-art...